Portugal Will Subsidise 15% of Obesity Medications
17 Articles
17 Articles
New drugs for rapid weight loss will be shared by the state, but are reserved for SNS specialists. Ordinance published this Thursday also limits the prescription to endocrinologists, internists or pediatricians, and up to a year
According to the decree, the drugs concerned, in order to benefit from the sharing (scale D), should be prescribed by physicians specialists in endocrinology, internal medicine or pediatrics, who integrate the Center for Hospital Care of the BME of the respective ULS.
Observador
In order to benefit from sharing, they should be prescribed by specialists in endocrinology, internal medicine or pediatrics, who integrate the Center for Hospital Care of the BME.
The participation lasts 12 months, which corresponds to the minimum intervention time foreseen in the Integrated Care Course for People with Obesity (PCIPO) for evaluation of therapeutic success or failure.
State will share anti-obesity medications from February 2027, but there are requirements to access support.
Support is reserved for patients accompanied by multidisciplinary hospital teams, with plans that include physical activity and nutritional and psychological follow-up.
Coverage Details
Bias Distribution
- 67% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
